{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:45Z","timestamp":1786982205204,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,4,17]],"date-time":"2011-04-17T00:00:00Z","timestamp":1302998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12032-011-9935-7","type":"journal-article","created":{"date-parts":[[2011,4,16]],"date-time":"2011-04-16T11:47:13Z","timestamp":1302954433000},"page":"1304-1307","source":"Crossref","is-referenced-by-count":15,"title":["Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Jennifer","family":"Rauw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheeda","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,17]]},"reference":[{"issue":"36","key":"9935_CR1","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"MB Charles","year":"2009","unstructured":"Charles MB, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol"},{"issue":"6","key":"9935_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","volume":"27","author":"S Slijfer","year":"2005","unstructured":"Slijfer S, et al. Side effects of interferon-a treatment. Pharm World Sci. 2005;27(6):423\u201331.","journal-title":"Pharm World Sci"},{"issue":"3","key":"9935_CR3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","volume":"99","author":"M Sonnenblick","year":"1991","unstructured":"Sonnenblick M, Rosin A. Cardiotoxicity of interferon A review of 44 cases. Chest. 1991;99(3):557\u201361.","journal-title":"Chest"},{"key":"9935_CR4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(88)80094-9","volume":"85","author":"M Cohen","year":"1988","unstructured":"Cohen M, Huberman M, Nesto R. Recombinant alpha 2 interferon- related cardiomyopathy. Am J Med. 1988;85:549\u201351.","journal-title":"Am J Med"},{"issue":"4","key":"9935_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/cbr.1994.9.291","volume":"9","author":"S Zimmerman","year":"1994","unstructured":"Zimmerman S, et al. Irreversible, severe congestive cardiomyopathy occurring in association with interferon alpha therapy. Cancer Biother. 1994;9(4):291\u20139.","journal-title":"Cancer Biother"},{"issue":"10","key":"9935_CR6","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T","volume":"74","author":"WH Kruit","year":"1994","unstructured":"Kruit WH, et al. Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpected frequent complication. Cancer. 1994;74(10):2850\u20136.","journal-title":"Cancer"},{"issue":"1","key":"9935_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1536\/ihj.37.137","volume":"31","author":"H Teragawa","year":"1996","unstructured":"Teragawa H, et al. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report. Jpn Heart J. 1996;31(1):137\u201342.","journal-title":"Jpn Heart J"},{"key":"9935_CR8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/08860220701641579","volume":"29","author":"A Sikole","year":"2007","unstructured":"Sikole A, et al. Treatment of hepatitis C in hemodialysis patients with pegulated interferon alpha-2a as monotherapy. Ren Fail. 2007;29:961\u20131099.","journal-title":"Ren Fail"},{"key":"9935_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s100670050081","volume":"18","author":"A Boonen","year":"1999","unstructured":"Boonen A, Stockbrugger RW, van der Linden S. Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol. 1999;18:177\u20139.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"9935_CR10","first-page":"719","volume":"20","author":"LA Nikolaidis","year":"2004","unstructured":"Nikolaidis LA, et al. Hepatitis C virus-associated pericardial effusion and tamponade in liver transplant recipient. Can J Cardiol. 2004;20(7):719\u201321.","journal-title":"Can J Cardiol"},{"key":"9935_CR11","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/ndt\/14.10.2469","volume":"14","author":"H Vacher-Coponat","year":"1994","unstructured":"Vacher-Coponat H, et al. Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with alpha interferon. Nephrol Dial Transplant. 1994;14:2469\u201371.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"9935_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncpcardio0069","volume":"2","author":"AY Khakoo","year":"2005","unstructured":"Khakoo AY, Halushka MK, Rame JE. Reversible cardiomyopathy caused by administration of interferon \u03b1. Nat Clin Prac Cardiovascular Med. 2005;2(1):53\u20137.","journal-title":"Nat Clin Prac Cardiovascular Med"},{"key":"9935_CR13","first-page":"486","volume":"9","author":"O Benjamini","year":"2007","unstructured":"Benjamini O, Kimhi O, Lishner M. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. IMAJ. 2007;9:486\u20137.","journal-title":"IMAJ"},{"issue":"5","key":"9935_CR14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.23251","volume":"112","author":"A Hauschild","year":"2008","unstructured":"Hauschild A, et al. Practical guidelines for the management of interferon-a-2b Side effects in patients receiving adjuvant treatment for melanoma. Cancer. 2008;112(5):982\u201394.","journal-title":"Cancer"},{"issue":"3","key":"9935_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1536\/jhj.44.447","volume":"44","author":"CT Lin","year":"2003","unstructured":"Lin CT, et al. Myxedema associated with cardiac tamponade. Jpn Heart J. 2003;44(3):447\u201350.","journal-title":"Jpn Heart J"},{"key":"9935_CR16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","volume":"354","author":"H Gogas","year":"2006","unstructured":"Gogas H, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006;354:709\u201318.","journal-title":"N Engl J Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-9935-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9935-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:09Z","timestamp":1559427729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-9935-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,17]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9935"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-9935-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,17]]}}}